Showing results (2121-2130 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|February 24, 2022
Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equation for estimating glomerular filtration rateJawad H Butt, Carly Adamson, Kieran F Docherty, et al.
European Journal of Heart Failure|February 24, 2022
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trialJoão Pedro Ferreira, Job A J Verdonschot, Nicolas Girerd, et al.
European Journal of Heart Failure|January 22, 2022
Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experienceMirjam G Wild, Felix Kreidel, Michaela M Hell, et al.
European Journal of Heart Failure|January 22, 2022
Cardiac autonomic neuropathy and risk of incident heart failure among adults with type 2 diabetesArnaud D Kaze, Matthew F Yuyun, Sebhat Erqou, et al.
European Journal of Heart Failure|July 5, 2019
Retinal microvascular dysfunction in patients with coronary artery disease with and without heart failure: a continuum?Jens Barthelmes, Matthias P Nägele, Silviya Cantatore, et al.
European Journal of Heart Failure|December 13, 2000
Relationship between left ventricular wall stress and ANP gene expression during the evolution of rapid ventricular pacing-induced heart failure in the dogA Luchner, D D Borgeson, J A Grantham, et al.
European Journal of Heart Failure|December 13, 2000
Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonistsB Chatterjee, U E Nydegger, P Mohacsi
European Journal of Heart Failure|December 13, 2000
Effect of beta 1 blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalaprilB Sturm, R Pacher, J Strametz-Juranek, et al.
European Journal of Heart Failure|December 13, 2000
A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the communityK F Fox, M R Cowie, D A Wood, et al.
European Journal of Heart Failure|December 13, 2000
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study GroupM J Sculpher, L Poole, J Cleland, et al.
Pageof 398